Please provide your email address to receive an email when new articles are posted on . A prospective study of community-dwelling older adults demonstrated an independent relationship between silent ...

Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...

NEW ORLEANS -- Adding the PCSK9 inhibitor evolocumab (Repatha) to stable lipid-lowering therapy reduced major adverse cardiac events (MACE) in patients with atherosclerosis or high-risk diabetes, but ...

Older adults hospitalized with infections had a significantly higher risk of developing dementia, according to an October study published in Aging-US.

Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables ...

Please provide your email address to receive an email when new articles are posted on . Dhamoon and colleagues analyzed 100% de-identified inpatient, outpatient and subacute nursing Medicare data from ...

Bundled cardioprotective medications with simplified delivery reduced the risk of hospitalization for myocardial infarction or stroke among patients at high risk. To assess the effect of promoting a ...

Discover how even low intensity smoking raises long term heart risks. Keep reading to learn why quitting early matters.

Can you have a stroke and not know it? Unfortunately, yes. It is a phenomenon called a silent stroke or, more formally, a silent cerebral infarction. Investigators at the University of Alabama at ...

Background: Rates of death from cardiovascular and cerebrovascular diseases have been steadily declining over the past few decades. Whether such declines are occurring to a similar degree for common ...